Seven Bridges

Company profile

About Seven Bridges

Seven Bridges is a leading biomedical data company specializing in software and data analytics to drive public and private healthcare research. The company enables researchers to extract meaningful insights from genomic and phenotypic data to advance precision medicine. Seven Bridges delivers end-to-end bioinformatic solutions that speed the path from raw experimental data to new treatments and diagnostics. The Seven Bridges Ecosystem consists of a compliant analytic platform, intelligently curated content, transformative algorithms, unprecedented access to federated datasets, and expert on-demand professional services. The platform is a cloud-based environment for conducting bioinformatic analyses at scale, serving as a central hub for teams to store, analyze, and jointly interpret their bioinformatic data. It co-locates analysis pipelines alongside the largest genomic datasets to optimize processing and allocates storage and compute resources on demand. The company serves researchers at the world's leading academic, biotechnology, clinical diagnostic, government, medical centers, and pharmaceutical entities. Seven Bridges helps organizations increase R&D efficiency, enhance the hypothesis resolution process, isolate critical biomarkers, and reduce computational workflow times and data storage costs. The company has been acquired by Velsera, which now offers all Seven Bridges products and services plus integrated solutions. Seven Bridges' innovative Graph Genome technology (GRAF) represents a breakthrough in representing and analyzing genomic information using graphs rather than strings of bases, allowing for unprecedented scale and accuracy in detecting genetic variation.

Company description · Seven Bridges official website